β-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD +, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation

Research output: Contribution to journalComment/debate

5 Scopus citations

Abstract

The clinical utility of cisplatin is limited by nephrotoxicity. Oh et al. report that β-lapachone prevents this nephrotoxicity but not cisplatin's cytotoxicity for cancers. In addition to its potential clinical importance, the beneficial effect of β-lapachone on cisplatin acute kidney injury may illustrate fundamental processes that ordinarily link alterations in nutrient availability and intracellular reactive oxygen species on the one hand, with inflammation and cell death on the other hand.

Original languageEnglish (US)
Pages (from-to)496-498
Number of pages3
JournalKidney international
Volume85
Issue number3
DOIs
StatePublished - Mar 2014

    Fingerprint

ASJC Scopus subject areas

  • Nephrology

Cite this